OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis
Scott P. Allen, Benjamin Hall, Lydia M. Castelli, et al.
Brain (2019) Vol. 142, Iss. 3, pp. 586-605
Open Access | Times Cited: 92

Showing 26-50 of 92 citing articles:

Why should we care about astrocytes in a motor neuron disease?
Katarina Stoklund Dittlau, Ludo Van Den Bosch
Frontiers in Molecular Medicine (2023) Vol. 3
Open Access | Times Cited: 14

The Inflammatory Puzzle: Piecing together the Links between Neuroinflammation and Amyotrophic Lateral Sclerosis
Di He, Yan Xu, Mingsheng Liu, et al.
Aging and Disease (2023) Vol. 15, Iss. 1, pp. 96-96
Open Access | Times Cited: 13

GDF15 Protects Insulin-Producing Beta Cells against Pro-Inflammatory Cytokines and Metabolic Stress via Increased Deamination of Intracellular Adenosine
Anongnad Ngamjariyawat, Jing Cen, Xuan Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 801-801
Open Access | Times Cited: 5

Astrocytes in Neurodegeneration: Inspiration From Genetics
Jingxuan Huang, Chunyu Li, Huifang Shang
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 21

Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1
Restuadi Restuadi, Frederik J. Steyn, Edor Kabashi, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 20

Inosine in Neurodegenerative Diseases: From the Bench to the Bedside
Maria Sofia Basile, Placido Bramanti, Emanuela Mazzon
Molecules (2022) Vol. 27, Iss. 14, pp. 4644-4644
Open Access | Times Cited: 20

Regulation of cortical hyperexcitability in amyotrophic lateral sclerosis: focusing on glial mechanisms
Manling Xie, Praveen N. Pallegar, Sebastian Parusel, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 12

Two-sample Mendelian randomization analysis of 91 circulating inflammatory protein levels and amyotrophic lateral sclerosis
Chenxu Xiao, Xiaochu Gu, Yu Feng, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 4

Neuroglia in neurodegeneration: Amyotrophic lateral sclerosis and frontotemporal dementia
Fabiola De Marchi, Edoardo Gioele Spinelli, Caterina Bendotti
Handbook of clinical neurology (2025), pp. 45-67
Closed Access

Mini-Review: Induced pluripotent stem cells and the search for new cell-specific ALS therapeutic targets
Laura Ferraiuolo, Nicholas J. Maragakis
Neuroscience Letters (2021) Vol. 755, pp. 135911-135911
Open Access | Times Cited: 24

Kynurenine pathway metabolites modulated the comorbidity of IBD and depressive symptoms through the immune response
Weiming Lai, Ziheng Huang, Sheng Li, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109840-109840
Closed Access | Times Cited: 10

Transcriptomic Analysis of Human Astrocytes In Vitro Reveals Hypoxia-Induced Mitochondrial Dysfunction, Modulation of Metabolism, and Dysregulation of the Immune Response
Scott P. Allen, Rajpinder S. Seehra, Paul R. Heath, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8028-8028
Open Access | Times Cited: 27

Rescuing compounds for Lesch-Nyhan disease identified using stem cell–based phenotypic screening
Valentin Ruillier, Johana Tournois, Claire Boissart, et al.
JCI Insight (2020) Vol. 5, Iss. 4
Open Access | Times Cited: 25

Adipose-derived stem cells protect motor neurons and reduce glial activation in both in vitro and in vivo models of ALS
Yuri Ciervo, Noemi Gatto, Chloe Allen, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 21, pp. 413-433
Open Access | Times Cited: 21

CuATSM effectively ameliorates ALS patient astrocyte‐mediated motor neuron toxicity in human in vitro models of amyotrophic lateral sclerosis
Cassandra N. Dennys, Florence Roussel, Rochelle Rodrigo, et al.
Glia (2022) Vol. 71, Iss. 2, pp. 350-365
Open Access | Times Cited: 14

Examining the relationship between astrocyte dysfunction and neurodegeneration in ALS using hiPSCs
Madeline Halpern, Kristen Brennand, James A. Gregory
Neurobiology of Disease (2019) Vol. 132, pp. 104562-104562
Open Access | Times Cited: 25

Glial Cell Dysfunction in C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Mehdi Ghasemi, Kiandokht Keyhanian, Catherine Douthwright
Cells (2021) Vol. 10, Iss. 2, pp. 249-249
Open Access | Times Cited: 20

Amyotrophic lateral sclerosis alters the metabolic aging profile in patient derived fibroblasts
Margarita Gerou, Benjamin Hall, Ryan Woof, et al.
Neurobiology of Aging (2021) Vol. 105, pp. 64-77
Open Access | Times Cited: 20

Astrocytic C–X–C motif chemokine ligand-1 mediates β-amyloid-induced synaptotoxicity
Beatriz Gomez Perez‐Nievas, Louisa Johnson, Paula Beltran-Lobo, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 20

Adenosinergic Signaling as a Key Modulator of the Glioma Microenvironment and Reactive Astrocytes
Gabriela Nogueira Debom, Dominique S. Rubenich, Elizandra Braganhol
Frontiers in Neuroscience (2022) Vol. 15
Open Access | Times Cited: 13

Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosis
Sarah L. Boddy, Mahjabin Islam, Tobias Moll, et al.
Brain Communications (2022) Vol. 4, Iss. 2
Open Access | Times Cited: 13

Desloratadine alleviates ALS-like pathology in hSOD1G93A mice via targeting 5HTR2A on activated spinal astrocytes
Jian Lu, Andong He, Zhuo-ying Jin, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 5, pp. 926-944
Closed Access | Times Cited: 2

Identification of the abnormalities in astrocytic functions as potential drug targets for neurodegenerative disease
Valtteri Syvänen, Jari Koıstınaho, Šárka Lehtonen
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 5, pp. 603-616
Closed Access | Times Cited: 2

Scroll to top